Improving Sleep in Rehabilitation After Stroke (INSPIRES)
Primary Purpose
Stroke
Status
Unknown status
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Digital cognitive behavioural therapy for insomnia
Sleep hygiene information
Sponsored by

About this trial
This is an interventional treatment trial for Stroke focused on measuring Sleep, Rehabilitation, Digital, Cognitive Behavioural Therapy for Insomnia
Eligibility Criteria
Inclusion Criteria:
- Participant is willing and able to give informed consent for participation in the study.
- At least 18 years of age
- At least 3 months post stroke
- Interest in improving sleep
- Can understand verbal and written English well enough to engage with the programme and study procedures (with assistance from carer if needed).
- Reliable access to internet
- Currently living in the United Kingdom
- Current stable health
Exclusion Criteria:
- Serious physical health concerns with surgery scheduled in the next 5 months
- Undergoing a psychological treatment programme for insomnia (with a health professional or online)
- Pregnancy
- Uncontrolled seizures
- Untreated diagnosed obstructive sleep apnoea
- Habitual night shift, evening or rotating shift-workers
- Other serious clinical condition that may affect participation in the study
Sites / Locations
- Wellcome Centre for Integrative Neuroimaging (WIN)
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Digital CBT-I
Sleep hygiene information
Arm Description
6 weeks digital (online) cognitive behavioural therapy for insomnia
Leaflet of sleep hygiene information
Outcomes
Primary Outcome Measures
Change in Sleep Condition Indicator score
Self-reported sleep quality questionnaire, range 0-32, higher numbers indicate better sleep quality
Secondary Outcome Measures
Maintenance of change in Sleep Condition Indicator score
Self-reported sleep quality questionnaire, range 0-32, higher scores indicate better sleep quality
Change in sleep fragmentation
Sleep fragmentation assessed using actigraphy, higher values indicate more disrupted sleep
Maintenance of change in sleep fragmentation
Sleep fragmentation assessed using actigraphy, higher values indicate more disrupted sleep
Change in wake after sleep onset
Wake after sleep onset assessed using actigraphy, higher values indicate more disrupted sleep
Maintenance of change in wake after sleep onset
Wake after sleep onset assessed using actigraphy, higher values indicate more disrupted sleep
Change in sleep onset latency
Sleep onset latency assessed using online sleep diary, higher values indicate poorer sleep quality
Maintenance of change in sleep onset latency
Sleep onset latency assessed using online sleep diary, higher values indicate poorer sleep quality
Change in self-reported depression
Change in PHQ9, range 0-20, higher values indicate more depressive symptoms
Maintenance of change in self-reported depression
Change in PHQ9, range 0-20, higher values indicate more depressive symptoms
Change in self-reported anxiety
Change in GAD7, range 0-21, higher values indicate more anxiety symptoms
Maintenance of change in self-reported anxiety
Change in GAD7, range 0-21, higher values indicate more anxiety symptoms
Change in stroke specific quality of life
Change in SIS-8, range 0-40, higher values less impact of stroke on quality of life
Maintenance of change in stroke specific quality of life
Change in SIS-8, range 0-40, higher values indicate less impact of stroke on quality of life
Full Information
NCT ID
NCT04272892
First Posted
February 13, 2020
Last Updated
July 20, 2021
Sponsor
University of Oxford
Collaborators
Big Health Inc.
1. Study Identification
Unique Protocol Identification Number
NCT04272892
Brief Title
Improving Sleep in Rehabilitation After Stroke
Acronym
INSPIRES
Official Title
An Investigation Into the Efficacy of Online Cognitive Behavioural Therapy for Insomnia ("Sleepio") to Improve Sleep After Stroke.
Study Type
Interventional
2. Study Status
Record Verification Date
July 2021
Overall Recruitment Status
Unknown status
Study Start Date
February 14, 2020 (Actual)
Primary Completion Date
October 2021 (Anticipated)
Study Completion Date
January 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Oxford
Collaborators
Big Health Inc.
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study evaluates the efficacy of digital cognitive behavioural therapy for insomnia (Sleepio) in chronic stroke survivors. Half of the participants will receive access to the digital (online) programme, half will receive a leaflet with sleep hygiene information. The primary outcome will be changes in sleep quality, assessed as the score on the Sleep Condition Indicator.
Detailed Description
Stroke is one of the leading causes of adult disability. Many stroke survivors report difficulties with sleep and our current research confirms this, indicating that chronic community dwelling stroke survivors experience poorer self-reported and objective sleep quality than age matched healthy controls.
"Sleepio" is an online Cognitive Behavioural Therapy for Insomnia (CBT-I) programme. The efficacy of this intervention has been demonstrated in people with chronic insomnia but has not yet been tested in people with stroke. The study therefore aims to determine whether digital CBT-I is effective for improving sleep quality in chronic stroke survivors. Participants will be randomised to receive either digital (online) CBT-I or a leaflet with sleep hygiene information. The primary outcome is the change in self-reported sleep quality, assessed using the Sleep Condition Indicator. Secondary outcomes include changes in sleep fragmentation and wake after sleep onset assessed with actigraphy, self-reported sleep onset latency from the sleep diaries, anxiety and depression using the PHQ9 and GAD7, quality of life using the SIS-8 and EQ-5D-5L as well as changes in healthcare costs during the 8 week follow up.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
Sleep, Rehabilitation, Digital, Cognitive Behavioural Therapy for Insomnia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants will be randomised (1:1 ratio) to the intervention or control group, using a computer generated minimisation method, with minimisation of between groups differences in age and baseline self-reported sleep quality (sleep condition indicator score)
Masking
Participant
Masking Description
Participants will be told that they will be assigned to one of two groups but will not be told whether one is hypothesised to be superior over another
Allocation
Randomized
Enrollment
86 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Digital CBT-I
Arm Type
Experimental
Arm Description
6 weeks digital (online) cognitive behavioural therapy for insomnia
Arm Title
Sleep hygiene information
Arm Type
Active Comparator
Arm Description
Leaflet of sleep hygiene information
Intervention Type
Behavioral
Intervention Name(s)
Digital cognitive behavioural therapy for insomnia
Other Intervention Name(s)
Sleepio
Intervention Description
6 weeks of cognitive behavioural therapy for insomnia (Sleepio) delivered online
Intervention Type
Behavioral
Intervention Name(s)
Sleep hygiene information
Intervention Description
A leaflet detailing advice to improve sleep through changes in sleep hygiene
Primary Outcome Measure Information:
Title
Change in Sleep Condition Indicator score
Description
Self-reported sleep quality questionnaire, range 0-32, higher numbers indicate better sleep quality
Time Frame
8 weeks
Secondary Outcome Measure Information:
Title
Maintenance of change in Sleep Condition Indicator score
Description
Self-reported sleep quality questionnaire, range 0-32, higher scores indicate better sleep quality
Time Frame
16 weeks
Title
Change in sleep fragmentation
Description
Sleep fragmentation assessed using actigraphy, higher values indicate more disrupted sleep
Time Frame
8 weeks
Title
Maintenance of change in sleep fragmentation
Description
Sleep fragmentation assessed using actigraphy, higher values indicate more disrupted sleep
Time Frame
16 weeks
Title
Change in wake after sleep onset
Description
Wake after sleep onset assessed using actigraphy, higher values indicate more disrupted sleep
Time Frame
8 weeks
Title
Maintenance of change in wake after sleep onset
Description
Wake after sleep onset assessed using actigraphy, higher values indicate more disrupted sleep
Time Frame
16 weeks
Title
Change in sleep onset latency
Description
Sleep onset latency assessed using online sleep diary, higher values indicate poorer sleep quality
Time Frame
8 weeks
Title
Maintenance of change in sleep onset latency
Description
Sleep onset latency assessed using online sleep diary, higher values indicate poorer sleep quality
Time Frame
16 weeks
Title
Change in self-reported depression
Description
Change in PHQ9, range 0-20, higher values indicate more depressive symptoms
Time Frame
8 weeks
Title
Maintenance of change in self-reported depression
Description
Change in PHQ9, range 0-20, higher values indicate more depressive symptoms
Time Frame
16 weeks
Title
Change in self-reported anxiety
Description
Change in GAD7, range 0-21, higher values indicate more anxiety symptoms
Time Frame
8 weeks
Title
Maintenance of change in self-reported anxiety
Description
Change in GAD7, range 0-21, higher values indicate more anxiety symptoms
Time Frame
16 weeks
Title
Change in stroke specific quality of life
Description
Change in SIS-8, range 0-40, higher values less impact of stroke on quality of life
Time Frame
8 weeks
Title
Maintenance of change in stroke specific quality of life
Description
Change in SIS-8, range 0-40, higher values indicate less impact of stroke on quality of life
Time Frame
16 weeks
Other Pre-specified Outcome Measures:
Title
Cost effectiveness
Description
Assessed as incremental cost effectiveness ratio, using EQ-5D-5L, range 0-5 for each dimension, higher values indicate more problems
Time Frame
16 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Participant is willing and able to give informed consent for participation in the study.
At least 18 years of age
At least 3 months post stroke
Interest in improving sleep
Can understand verbal and written English well enough to engage with the programme and study procedures (with assistance from carer if needed).
Reliable access to internet
Currently living in the United Kingdom
Current stable health
Exclusion Criteria:
Serious physical health concerns with surgery scheduled in the next 5 months
Undergoing a psychological treatment programme for insomnia (with a health professional or online)
Pregnancy
Uncontrolled seizures
Untreated diagnosed obstructive sleep apnoea
Habitual night shift, evening or rotating shift-workers
Other serious clinical condition that may affect participation in the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Heidi Johansen-Berg, PhD
Organizational Affiliation
University of Oxford, UK
Official's Role
Principal Investigator
Facility Information:
Facility Name
Wellcome Centre for Integrative Neuroimaging (WIN)
City
Oxford
ZIP/Postal Code
OX3 9DU
Country
United Kingdom
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
De-identified data are available upon reasonable request
IPD Sharing Time Frame
Following publication of results
IPD Sharing Access Criteria
Available upon reasonable request
Learn more about this trial
Improving Sleep in Rehabilitation After Stroke
We'll reach out to this number within 24 hrs